Patents by Inventor Qingzhi Gao

Qingzhi Gao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6960573
    Abstract: Compounds expressed by the following general formula (1), [wherein, R01 and R02 are each independently a hydrogen atom or a protecting group for a hydroxyl group; Z is one out of the following formulae (1-1), (1-2), (1-3), (1-4) and (1-5)]. The compounds can be used as active ingredients of treating agents for inflammatory respiratory diseases, malignant tumors, rheumatoid arthritis, osteoporosis, diabetes mellitus, hypertension, alopecia, acne, psoriasis, dermatitis, hypercalcemia, hypoparathyroidism and metabolic disorder of cartilage.
    Type: Grant
    Filed: January 4, 2002
    Date of Patent: November 1, 2005
    Assignee: Teijin Limited
    Inventors: Kazuya Takenouchi, Qingzhi Gao, Kenji Manabe, Ryo Sogawa, Yasuhiro Takano, Seiichi Ishizuka
  • Publication number: 20050101574
    Abstract: An agent for suppressing the production of parathyroid hormone and a remedy for hyperparathyroidism containing a vitamin D3 derivative described by the following general formula (1) [in the formula, m is an integer of from 1 to 3, q is an integer of from 0 to 3, r is an integer of from 0 to 3 and X is carbon atom or oxygen atom, provided that 1?q+r?3] as an active ingredient.
    Type: Application
    Filed: August 29, 2001
    Publication date: May 12, 2005
    Inventors: Seiichi Ishizuka, Daishiro Miura, Kenji Manabe, Qingzhi Gao, Ryo Sogawa, Kazuya Takenouchi
  • Patent number: 6867313
    Abstract: Compounds expressed by the following general formula (1), [wherein, R01 and R02 are each independently a hydrogen atom or a protecting group for a hydroxyl group; Z is one out of the following formulae (1-1) to (1-5)]. The compounds can be used as active ingredients of treating agents for inflammatory respiratory diseases, malignant tumors, rheumatoid arthritis, osteoporosis, diabetes mellitus, hypertension, alopecia, acne, psoriasis, dermatitis, hypercalcemia, hypoparathyroidism and metabolic disorder of cartilage.
    Type: Grant
    Filed: January 4, 2002
    Date of Patent: March 15, 2005
    Assignee: Teijin Limited
    Inventors: Kazuya Takenouchi, Qingzhi Gao, Kenji Manabe, Ryo Sogawa, Yasuhiro Takano, Seiichi Ishizuka
  • Patent number: 6689766
    Abstract: Compounds expressed by the following general formula (1), [wherein, R01 and R02 are each independently a hydrogen atom or a protecting group for a hydroxyl group; Z is one out of the following formula (1-5)]. The compounds can be used as active ingredients of treating agents for inflammatory respiratory diseases, malignant tumors, rheumatoid arthritis, osteoporosis, diabetes mellitus, hypertension, alopecia, acne, psoriasis, dermatitis, hypercalcemia, hypoparathyroidism and metabolic disorder of cartilage.
    Type: Grant
    Filed: January 4, 2002
    Date of Patent: February 10, 2004
    Assignee: Teijin Limited
    Inventors: Kazuya Takenouchi, Qingzhi Gao, Kenji Manabe, Ryo Sogawa, Yasuhiro Takano, Seiichi Ishizuka
  • Patent number: 6548489
    Abstract: Compounds expressed by the following general formula (1), [wherein, R01 and R02 are each independently a hydrogen atom or a protecting group for a hydroxyl group; Z is one out of the following formulae (1-1) to (1-5)]. The compounds can be used as active ingredients of treating agents for inflammatory respiratory diseases, malignant tumors, rheumatoid arthritis, osteoporosis, diabetes mellitus, hypertension, alopecia, acne, psoriasis, dermatitis, hypercalcemia, hypoparathyroidism and metabolic disorder of cartilage.
    Type: Grant
    Filed: January 4, 2002
    Date of Patent: April 15, 2003
    Assignee: Teijin Limited
    Inventors: Kazuya Takenouchi, Qingzhi Gao, Kenji Manabe, Ryo Sogawa, Yasuhiro Takano, Seiichi Ishizuka
  • Patent number: 6531460
    Abstract: Compounds expressed by the following general formula (1), The compounds can be used as active ingredients of treating agents for inflammatory respiratory diseases, malignant tumors, rheumatoid arthritis, osteoporosis, diabetes mellitus, hypertension; alopecia, acne, psoriasis, dermatitis, hypercalcemia, hypoparathyroidism and metabolic disorder of cartilage.
    Type: Grant
    Filed: April 23, 2001
    Date of Patent: March 11, 2003
    Assignee: Teijin Limited
    Inventors: Kazuya Takenouchi, Qingzhi Gao, Kenji Manabe, Ryo Sogawa, Yasuhiro Takano, Seiichi Ishizuka
  • Publication number: 20020132799
    Abstract: Compounds expressed by the following general formula (1), 1
    Type: Application
    Filed: January 4, 2002
    Publication date: September 19, 2002
    Applicant: TEIJIN LIMITED
    Inventors: Kazuya Takenouchi, Qingzhi Gao, Kenji Manabe, Ryo Sogawa, Yasuhiro Takano, Seiichi Ishizuka
  • Publication number: 20020103173
    Abstract: Compounds expressed by the following general formula (1), 1
    Type: Application
    Filed: January 4, 2002
    Publication date: August 1, 2002
    Applicant: TEIJIN LIMITED
    Inventors: Kazuya Takenouchi, Qingzhi Gao, Kenji Manabe, Ryo Sogawa, Yasuhiro Takano, Seiichi Ishizuka
  • Publication number: 20020099039
    Abstract: Compounds expressed by the following general formula (1), 1
    Type: Application
    Filed: January 4, 2002
    Publication date: July 25, 2002
    Applicant: TEIJIN LIMITED
    Inventors: Kazuya Takenouchi, Qingzhi Gao, Kenji Manabe, Ryo Sogawa, Yasuhiro Takano, Seiichi Ishizuka
  • Publication number: 20020091109
    Abstract: Compounds expressed by the following general formula (1), 1
    Type: Application
    Filed: January 4, 2002
    Publication date: July 11, 2002
    Applicant: TEIJIN LIMITED
    Inventors: Kazuya Takenouchi, Qingzhi Gao, Kenji Manabe, Ryo Sogawa, Yasuhiro Takano, Seiichi Ishizuka
  • Patent number: 6028208
    Abstract: Provided are vitamin D.sub.3 derivatives expressed by the following general formula [1] ##STR1## [wherein, R.sub.1 and R.sub.2 are each a hydrogen atom, a trialkylsilyl group, an acetyl group, a methoxymethyl group, or a tetrahydropyranyl group; R.sub.3 and R.sub.4 are each a hydrogen atom, a hydroxyl group, an acyloxy group, an alkyloxy group, an alkylthio group or an alkyl group which is optionally substituted; R.sub.5, R.sub.6, R.sub.7 and R.sub.8 are each a hydrogen atom, a hydroxyl group, an alkyl group or an acyloxy group; R.sub.9 is a hydrogen atom, a hydroxyl group, an alkyl group or an alkylthio group; R.sub.10 is a hydrogen atom, an alkyl group or an alkyloxy group; A and B are each a hydrogen atom, a hydroxyl group, or together express a single bond; X and Y express a carbonyl oxygen, or one of them is a hydrogen atom and the other is a hydroxyl group or an acyloxy group; n is an integer of 0 to 2; m is an integer of 0 to 2], and a method for manufacturing the derivatives.
    Type: Grant
    Filed: February 22, 1999
    Date of Patent: February 22, 2000
    Assignee: Teijin Limited
    Inventors: Qingzhi Gao, Kenji Manabe, Minoru Furuya, Manabu Chokki, Hiroaki Mitsuhashi, Seiichi Ishizuka, Tadashi Kishimoto, Masayasu Tabe, Yasuji Sakuma, Atsuo Hazato, Hiroko Tanaka
  • Patent number: 5986112
    Abstract: A vitamin D.sub.3 derivative represented by the following formula: wherein, R is, independently, a hydrogen atom, tri(C.sub.1 to C.sub.7 hydrocarbon)silyl group, C.sub.2 to C.sub.8 acyl group, or group forming an acetal bond together with an oxygen atom of a hydroxyl group, A is ##STR1## where, R.sup.1 is a methyl group or methylene group, and when R.sup.1 is a methylene group, the bond between the R.sup.1 and the 3-position of the lactone ring is a double bond, R.sup.2 is a hydrogen atom or C.sub.1 to C.sub.3 alkyl group, R.sup.3 is a hydrogen atom, or R.sup.2 and R.sup.3 together indicate a substitutable single methylene group.
    Type: Grant
    Filed: November 14, 1997
    Date of Patent: November 16, 1999
    Assignee: Teijin Limited
    Inventors: Masayasu Tabe, Atsuo Hazato, Kenji Manabe, Qingzhi Gao, Hiroko Tanaka
  • Patent number: 5719297
    Abstract: A vitamin D.sub.3 derivative represented by the following formula: ##STR1## wherein, R is, independently, a hydrogen atom, tri(C.sub.1 to C.sub.7 hydrocarbon)silyl group, C.sub.2 to C.sub.8 acyl group, or group forming an acetal bond together with an oxygen atom of a hydroxyl group, A is ##STR2## where, R.sup.1 is a methyl group or methylene group, and when R.sup.1 is a methylene group, the bond between the R.sup.1 and the 3-position of the lactone ring is a double bond, R.sup.2 is a hydrogen atom or C.sub.1 to C.sub.3 alkyl group, R.sup.3 is a hydrogen atom, or R.sup.2 and R.sup.3 together indicate a substitutable single methylene group.
    Type: Grant
    Filed: February 6, 1996
    Date of Patent: February 17, 1998
    Assignee: Teijin Limited
    Inventors: Masayasu Tabe, Atsuo Hazato, Kenji Manabe, Qingzhi Gao, Hiroko Tanaka